CHONGQING, CHINA – JULY 27: In this photo illustration, a smartphone displays the logo of UnitedHealth Group Incorporated (NYSE: UNH), a leading American healthcare and insurance company, in front of a screen showing the company’s latest stock market chart on July 27, 2025 in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)
Getty Images
Warren Buffett’s Berkshire Hathaway revealed a $1.6 billion investment in UnitedHealth Group (NYSE: UNH) on August 15, 2025, causing the stock to rise by 11% in its best trading day since 2020. This investment signifies Buffett’s re-entry into UNH after liquidating his entire position back in 2010, indicating that he perceives significant value at the current lowered prices.
UnitedHealth now trades at 11 times trailing adjusted earnings, an increase from the 9 times low recorded earlier this month, yet it remains substantially below its five-year average of 21 times. While this confirms our earlier evaluation that the stock seems attractively priced, the underlying operational challenges still exist—medical cost ratios sitting at 89.4%, compressed profit margins, and a reduction in earnings guidance from $30 to $16 per share.
Certainly, Buffett’s endorsement lends psychological backing and implies that a potential low point is being established. However, the fundamental challenges that caused the stock to drop from $600 to $250 continue unabated. Management has indicated that no earnings growth is expected until 2026, underlining the lengthy recovery process ahead.
UnitedHealth’s current valuation discount, coupled with its endorsement by Warren Buffett, could signal a compelling opportunity for investors seeking to assume a higher degree of risk. In contrast, more conservative investors would be wise to delay investment until clear evidence of medical cost stabilization emerges. Ultimately, the company’s significant scale and diversified Optum segment position it for long-term strength, but success will require both patience and a high tolerance for market volatility.Additionally, see – Buy or Fear UNH Stock?
In summary, while Buffett’s $1.6 billion investment offers short-term technical backing and reinforces the value proposition, UNH remains a risky investment at current levels. Now, we employ a risk assessment framework while developing the Trefis High Quality (HQ) Portfolio, which, comprising 30 stocks, has a history of comfortably exceeding the S&P 500 over the last 4-year span. Why is that? As a collective, HQ Portfolio stocks have delivered superior returns with reduced risk compared to the benchmark index; they have experienced less volatility, as shown in HQ Portfolio performance metrics.
MORE FOR YOU